CL
ClearPoint Neuro, Inc.
CLPT · NASDAQ
$13.72 +0.51% (+$0.07)
1M -11.02%
Market Cap $404.3M
P/E Ratio -
Div. Yield -
ROE 188.09%
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/B 37.51x
P/S 9.56x
EV/EBITDA N/A
Growth
78 /100
Growing Book val. growth 8.76%
Rev. growth 21.62%
FCF growth N/A
Profitability
20 /100
Weak Net margin 81.76%
Op. margin 73.42%
FCF margin 74.01%
Quality
6 /100
Poor ROE 188.09%
ROA 39.85%
Asset turnover 0.49x
Debt
23 /100
High Current ratio 4.73x
Int. coverage -7.63x
Debt/Equity 5.93x
Stability
64 /100
Moderate Rev. volatility 8.03%
EPS volatility 30.48%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o CLPT
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Joseph Michael Burnett
Employees
172
Headquarters
Solana Beach
Nadchodzące wydarzenia
05 LIS
Earnings
Upcoming earnings report